Constitutive BAK activation as a determinant of drug sensitivity in malignant lymphohematopoietic cells.
Genes Dev
; 29(20): 2140-52, 2015 Oct 15.
Article
in En
| MEDLINE
| ID: mdl-26494789
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Gene Expression Regulation, Neoplastic
/
Transcriptional Activation
/
Drug Resistance, Neoplasm
/
Bcl-2 Homologous Antagonist-Killer Protein
Type of study:
Diagnostic_studies
/
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Genes Dev
Journal subject:
BIOLOGIA MOLECULAR
Year:
2015
Document type:
Article
Country of publication:
Estados Unidos